Independent studies show Purple Innovations® Essential and Restore mattresses, with GelFlex Grid® technology, show self-reported pain dropping by 63-68% and sleep quality and comfort significantly improving
Rhea-AI Summary
Purple (NASDAQ: PRPL) announced independent SleepScore Labs studies showing Purple Essentials and Purple Restore mattresses with GelFlex Grid reduced self-reported nighttime pain disruptions and improved measured sleep across two 10-week, in-home trials covering >3,300 nights.
Key results: pain reductions of 68% (Essentials) and 63% (Restore); Essentials users fell asleep 8% faster and woke 6% less often; Restore users gained +3.5 hours deep sleep/month and +7 hours total sleep/month, with sleep quality +3% and efficiency +2%. Self-reported morning restoration and satisfaction rose substantially for both collections.
Positive
- Self-reported pain disruption down 68% (Essentials)
- Self-reported pain disruption down 63% (Restore)
- Essentials: 8% faster sleep onset and 6% fewer awakenings
- Restore: +3.5 hours deep sleep per month
- Restore: +7 hours total sleep per month
- Large self-reported increases in morning restoration and satisfaction (up to 214%)
Negative
- None.
News Market Reaction
On the day this news was published, PRPL declined 4.00%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Sector moves appear stock-specific. IRBT showed a sharp decline of 71.75999879837036% and was the only peer in the momentum scanner, while other peers like HOFT (1.99%) and NVFY (-4.78%) had mixed, single-digit moves.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 04 | Q3 2025 earnings | Positive | +1.3% | Improved margins and narrowed net loss with guidance maintained. |
| Oct 29 | Earnings call notice | Neutral | -5.8% | Announcement of timing and access details for Q3 2025 results call. |
| Jul 29 | Q2 2025 earnings | Negative | -3.8% | Revenue declined despite improved adjusted EBITDA and reaffirmed guidance. |
| Jul 21 | Earnings call notice | Neutral | +7.2% | Scheduling and access information for upcoming Q2 2025 results. |
Limited history suggests earnings releases tend to move in the same direction as their tone, while conference-call scheduling headlines show more variable reactions.
Over the last six months, Purple reported Q2 and Q3 2025 results, showing revenue pressure but improving margins and a narrowing net loss, with Q3 $118.8M revenue and adjusted EBITDA turning slightly positive. The company repeatedly reaffirmed 2025 guidance and highlighted initiatives like Rejuvenate 2.0 and expanded Mattress Firm placement. Today’s product-validation news reinforces the strategy of differentiating through GelFlex Grid technology alongside ongoing operational restructuring and channel expansion.
Market Pulse Summary
This announcement details independent SleepScore Labs studies showing Purple’s Essentials and Restore mattresses with GelFlex Grid technology reduced self-reported pain by 63–68% and improved objective measures like time to fall asleep and deep sleep by 3.5 hours per month. These findings support Purple’s strategy of product-led differentiation seen alongside earlier earnings reports that highlighted margin improvement and reaffirmed 2025 guidance. Investors may watch for how this validation translates into demand and channel performance.
Key Terms
deep sleep medical
sleep efficiency medical
AI-generated analysis. Not financial advice.
In the news release, Independent studies show Purple Innovations® Essential and Restore mattresses, with GelFlex Grid® technology, show self-reported pain dropping by 63–
Independent studies show Purple Innovations® Essential and Restore mattresses, with GelFlex Grid® technology, show self-reported pain dropping by 63–68% and sleep quality and comfort significantly improving
Purple's GelFlex Grid® Mattresses Reduce Self-Reported Pain and Improves Sleep in Independent Studies by SleepScore Labs
Across two 10-week, in-home studies evaluating Purple's Essentials and Restore mattress collections compared to the research participants' sleep on their original mattresses, SleepScore Labs analyzed more than 3,300 nights of objective and self-reported sleep data. The results reaffirm the GelFlex Grid® as a uniquely effective comfort solution for people whose sleep is impacted by aches and pains.
Participants reported significant reductions in the degree to which nighttime pain interfered with their sleep, including a
"Participants reported substantial reductions in the impact of pain on their sleep, alongside changes observed in the sleep tracking data," said Dr. Sharon Danoff-Burg, Senior Principal Research Scientist at SleepScore Labs. "This combination of objective and subjective improvements speaks to the meaningful comfort and support delivered by the Purple Essentials and Purple Restore Mattresses containing GelFlex Grid technology."
Both studies demonstrated objectively measured improvements in participants' sleep, compared to when sleeping on their original mattress, including:
- Essentials users fell asleep
8% faster and woke up6% less often. - Restore users spent more time in deep sleep (+3.5 hours per month) and slept longer (+7 hours per month), along with better sleep quality (+
3% ) and efficiency (+2% ).
Participants also reported gains in how restored and satisfied they felt each morning:
- Feeling well-rested: +
96% (Essentials), +174% (Restore) - Self-Reported sleep quality: +
90% (Essentials), +170% (Restore) - Sleep satisfaction: +
127% (Essentials), +214% (Restore) - Restore users also reported a
204% increase in their ability to sleep through the night without tossing and turning
Because participants were asked not to change their nighttime routines or sleep environments other than the mattress, the results point to the meaningful impact of the mattress itself.
"These findings reinforce what we hear from Purple sleepers every day," said Rob DeMartini, Chief Executive Officer at Purple. "Our mattresses, featuring the GelFlex Grid, deliver powerful and measurable improvements in sleep and pain. Independent scientific validation confirms that our technology helps people fall asleep easier, sleep better through the night, and experience truly transformative rest. That is our mission: Less pain. Better sleep."
Purple's patented GelFlex Grid was originally developed for medical applications to reduce pressure and support patients with limited mobility. The technology is now central to Purple's mattress designs, offering a unique combination of pressure relief, alignment, and temperature balance.
"We are pleased to see such strong and consistent outcomes from Purple's mattresses with GelFlex Grid technology," said Colin Lawlor, CEO of Sleep.ai. "These results highlight the role that better-designed sleep surfaces can play in reducing pain-related sleep disruption and supporting deeper, more measurable rest. It's a strong validation of Purple's approach and a compelling example of how thoughtful innovation can improve people's nighttime recovery."
Interested partners who want to learn more about the findings can visit the Purple showroom during Las Vegas Winter Market on Monday, January 26, where the Head of Business Development from Sleep.ai will be available to discuss the study and answer questions.
About Purple
Purple exists to help people get the best sleep of their lives — by reducing pain, deepening sleep, and unlocking the potential for brighter dawns and better days. At the center of that mission is our signature innovation, the GelFlex Grid®. Originally developed in medical settings to support the body in its most vulnerable moments, the GelFlex Grid delivers a one-of-a-kind combination of pressure relief, alignment, and temperature balance that helps people fall asleep easier, stay asleep longer, and wake up with less pain.
That same comfort technology extends beyond mattresses into pillows, bedding, and cushions designed to make everyday life feel a little lighter and a lot more comfortable. Because when pain eases and sleep improves, everything else gets better too — your energy, your outlook, and your ability to show up for the moments that matter.
Less pain. Better sleep.
Learn more at www.purple.com
About Sleep.ai
Sleep.ai is a leading healthtech company and the world's most advanced sleep intelligence platform, powered by nearly 1 billion hours of objective sleep data and over 250 scientific studies. Through its APIs, SDKs, and consumer app, Sleep.ai enables partners to embed clinically validated, AI-driven sleep technology into their products.
SleepScore Labs, the company's research and validation division, is recognized globally for advancing sleep science. With over a decade of in-home studies and product trials, SleepScore Labs powers the data behind the Sleep.ai platform and validates sleep solutions across the consumer, health, and wellness industries.
Learn more at www.sleep.ai or on LinkedIn.
FAQ
What did Purple (PRPL) announce on December 15, 2025 about mattress study results?
How did Purple Restore (PRPL) mattresses affect deep sleep and total sleep in the study?
What specific benefits did Purple Essentials (PRPL) show in the SleepScore Labs study?
Are Purple's GelFlex Grid results from independent testing relevant to investors in PRPL?
Where and when can partners learn more about the SleepScore Labs findings for Purple (PRPL)?
